Table 3.
All patients | In high-risk patients | Unclear efficacy |
---|---|---|
Careful patient selection | Pancreatic duct stent placement | Nitrates |
Consider alternative modalities | Single-dose rectal indomethacin | Protease inhibitors |
Provider training and experience | Intravenous fluid hydration | |
Guide wire-assisted cannulation |